Cero Therapeutics Holdings Stock Probability of Future Stock Price Finishing Over 35.43
| CEROW Stock | 0.01 0.00 0.000004% |
CERo |
CERo Therapeutics Target Price Odds to finish over 35.43
The tendency of CERo Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move over 35.43 or more in 90 days |
| 0.01 | 90 days | 35.43 | close to zero percent |
Based on a normal probability distribution, the odds of CERo Therapeutics to move over 35.43 or more in 90 days from now is close to zero percent (This CERo Therapeutics Holdings probability density function shows the probability of CERo Stock to fall within a particular range of prices over 90 days) . Probability of CERo Therapeutics price to stay between its current price of 0.01 and 35.43 at the end of the 90-day period is about 60.8 .
Assuming the 90 days horizon CERo Therapeutics Holdings has a beta of -2.69 suggesting as returns on its benchmark rise, returns on holding CERo Therapeutics Holdings are expected to decrease by similarly larger amounts. On the other hand, during market turmoils, CERo Therapeutics is expected to outperform its benchmark. In addition to that CERo Therapeutics Holdings has an alpha of 5.6934, implying that it can generate a 5.69 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). CERo Therapeutics Price Density |
| Price |
Predictive Modules for CERo Therapeutics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as CERo Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.CERo Therapeutics Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. CERo Therapeutics is not an exception. The market had few large corrections towards the CERo Therapeutics' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold CERo Therapeutics Holdings, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of CERo Therapeutics within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 5.69 | |
β | Beta against Dow Jones | -2.69 | |
σ | Overall volatility | 0.01 | |
Ir | Information ratio | 0.16 |
CERo Therapeutics Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of CERo Therapeutics for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for CERo Therapeutics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| CERo Therapeutics is way too risky over 90 days horizon | |
| CERo Therapeutics has some characteristics of a very speculative penny stock | |
| CERo Therapeutics appears to be risky and price may revert if volatility continues | |
| CERo Therapeutics has high likelihood to experience some financial distress in the next 2 years | |
| CERo Therapeutics Holdings was previously known as Phoenix Biotech Acquisition and was traded on NASDAQ Exchange under the symbol PBAXW. | |
| Net Loss for the year was (2.54 K) with profit before overhead, payroll, taxes, and interest of 0. | |
| CERo Therapeutics generates negative cash flow from operations | |
| CERo Therapeutics has a frail financial position based on the latest SEC disclosures | |
| Latest headline from news.google.com: Cero Therapeutics holdings sees 400,456 in stock sales by YK Bioventures - Investing.com |
CERo Therapeutics Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of CERo Stock often depends not only on the future outlook of the current and potential CERo Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. CERo Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 6.5 M | |
| Cash And Short Term Investments | 96.9 K | |
| Shares Float | 22.5 M |
CERo Therapeutics Technical Analysis
CERo Therapeutics' future price can be derived by breaking down and analyzing its technical indicators over time. CERo Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of CERo Therapeutics Holdings. In general, you should focus on analyzing CERo Stock price patterns and their correlations with different microeconomic environments and drivers.
CERo Therapeutics Predictive Forecast Models
CERo Therapeutics' time-series forecasting models is one of many CERo Therapeutics' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary CERo Therapeutics' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about CERo Therapeutics
Checking the ongoing alerts about CERo Therapeutics for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for CERo Therapeutics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| CERo Therapeutics is way too risky over 90 days horizon | |
| CERo Therapeutics has some characteristics of a very speculative penny stock | |
| CERo Therapeutics appears to be risky and price may revert if volatility continues | |
| CERo Therapeutics has high likelihood to experience some financial distress in the next 2 years | |
| CERo Therapeutics Holdings was previously known as Phoenix Biotech Acquisition and was traded on NASDAQ Exchange under the symbol PBAXW. | |
| Net Loss for the year was (2.54 K) with profit before overhead, payroll, taxes, and interest of 0. | |
| CERo Therapeutics generates negative cash flow from operations | |
| CERo Therapeutics has a frail financial position based on the latest SEC disclosures | |
| Latest headline from news.google.com: Cero Therapeutics holdings sees 400,456 in stock sales by YK Bioventures - Investing.com |
Additional Tools for CERo Stock Analysis
When running CERo Therapeutics' price analysis, check to measure CERo Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CERo Therapeutics is operating at the current time. Most of CERo Therapeutics' value examination focuses on studying past and present price action to predict the probability of CERo Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CERo Therapeutics' price. Additionally, you may evaluate how the addition of CERo Therapeutics to your portfolios can decrease your overall portfolio volatility.